In addition, the potential protective capacity of EPO and Wnt1 during Alzheimer’s disease may be linked to the ability of EPO and Wnt1 to govern Bad, Bcl-xL, and caspase activity and increase microglial cell survival during Aβ toxicity [79]. This evidence concerns the gene EPO and early-onset autosomal dominant Alzheimer disease.